Deciding on the right vascular access device option for you depends on the treatment you need and other factors such as lifestyle and comfort.
The PortReady™ Program is a patient-information initiative focused on helping you, or a loved one, as you start apheresis therapy treatment. Apheresis therapy isn’t always easy, but we believe choosing the right vascular access device is an important first step. The PortReady™ Program is a resource that provides you with information regarding port placement, access, and care. The PortReady™ Program was developed to aid your port readiness journey.
Apheresis is a medical procedure that involves removing blood from a patient or donor and separating the blood into individual components. Once separated, the blood component that contains disease-provoking elements is removed. The remaining blood components are then re-introduced back into the bloodstream. Apheresis therapy can be conducted utilizing a variety of vascular access devices such as central venous catheters (CVC), and implantable ports. Talk to your healthcare team for further information about what’s best for you.
1 Nagel SN, Teichgräber UK, Kausche S, Lehmann A. Satisfaction and quality of life: a survey-based assessment in patients with a totally implantable venous port system. Eur J Cancer Care (Engl). 2012;21(2):197-204. doi:10.1111/j.1365-2354.2011.01275.x2
2 Padmanabhan A, Connelly- Smith L, Aqui N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34: 171–354. https://doi.org/10.1002/jca.21705